Influx Health.
: INFLUX · Pharmaceuticals
Snapshot
Unlock Influx Health.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Influx Healthtech Limited is a healthcare-focused company operating as a Contract Development and Manufacturing Organization (CDMO). It provides end-to-end manufacturing services, including formulation, development, and regulatory support for nutraceuticals, cosmetics, ayurvedic products, and veterinary supplements.
Business Model
The company operates on a B2B business model, providing contract manufacturing services to clients across various healthcare and personal care segments. Revenue is generated through the provision of product formulation, development, and commercialisation services.
Growth Outlook
Growth is expected to be driven by the increasing demand for outsourced manufacturing in the nutraceutical and herbal product sectors. The company leverages its end-to-end service capabilities to capture market share among B2B healthcare clients.
Key Risks
- Regulatory Compliance. The company faces risks related to stringent and evolving regulatory standards for nutraceuticals and herbal products in India.
- Client Concentration. As a CDMO, the company may be vulnerable to the loss of key B2B clients or fluctuations in their product demand.
- Input Cost Volatility. Fluctuations in the prices of raw materials and active ingredients could impact the company's manufacturing margins.
- Competitive Intensity. The contract manufacturing sector is highly fragmented, leading to significant pricing pressure from both domestic and international competitors.
Start your research today
Unlock AI insights, financials, peers and live data on Influx Health. and 5,000+ companies — free.
Peers · Pharmaceuticals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Influx Health.INFLUX | ₹701 Cr | — | — | — | 20.0% | — | — | +77.5% |
Amanta HealthcarAMANTA | ₹719 Cr | 44.50 | 13.94 | — | 21.5% | 6.7% | 9.9% | — |
Shree Ganesh Remedies LimitedSGRL | ₹696 Cr | 39.23 | 18.75 | — | 34.8% | 11.9% | 15.9% | -7.6% |
Bafna Pharmaceuticals LimitedBAFNAPH | ₹689 Cr | 88.48 | 40.61 | -3.1% | 12.5% | 8.6% | 10.3% | +180.3% |
Zim LaboratoriesZIMLAB | ₹672 Cr | 153.00 | 19.69 | 7.6% | 9.9% | 1.3% | 5.7% | +66.4% |
Kilitch Drugs (India) LimitedKILITCH | ₹601 Cr | 13.70 | 14.07 | 14.0% | 20.2% | 12.1% | 15.6% | -49.4% |
As of Mar 2026
Financials
Influx Health.
: INFLUX · Pharmaceuticals
Snapshot
Unlock Influx Health.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Influx Healthtech Limited is a healthcare-focused company operating as a Contract Development and Manufacturing Organization (CDMO). It provides end-to-end manufacturing services, including formulation, development, and regulatory support for nutraceuticals, cosmetics, ayurvedic products, and veterinary supplements.
Business Model
The company operates on a B2B business model, providing contract manufacturing services to clients across various healthcare and personal care segments. Revenue is generated through the provision of product formulation, development, and commercialisation services.
Growth Outlook
Growth is expected to be driven by the increasing demand for outsourced manufacturing in the nutraceutical and herbal product sectors. The company leverages its end-to-end service capabilities to capture market share among B2B healthcare clients.
Key Risks
- Regulatory Compliance. The company faces risks related to stringent and evolving regulatory standards for nutraceuticals and herbal products in India.
- Client Concentration. As a CDMO, the company may be vulnerable to the loss of key B2B clients or fluctuations in their product demand.
- Input Cost Volatility. Fluctuations in the prices of raw materials and active ingredients could impact the company's manufacturing margins.
- Competitive Intensity. The contract manufacturing sector is highly fragmented, leading to significant pricing pressure from both domestic and international competitors.
Start your research today
Unlock AI insights, financials, peers and live data on Influx Health. and 5,000+ companies — free.
Peers · Pharmaceuticals
As of Mar 2026